Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -221.32% is 271% below its 5-year average of -59.62%, near the low end of its 5-year range (-221.32%–9.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 49.49% below its 12-month average of -148.05%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -221.32%.
RETURN ON INVESTED CAPITAL (ROIC)
-221.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-148.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-93.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-59.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-77.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-49.49%
CURRENT VS 3Y AVG
-136.30%
CURRENT VS 5Y AVG
-271.19%
CURRENT VS 10Y AVG
-186.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-520.90%
vs the sector median at left
CollPlant Biotechnologies Ltd.
Market Cap
$4.40M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-148.05%
3Y Avg
-93.66%
5Y Avg
-59.62%
Market Cap
$4.32M
Return on Invested Capital (ROIC)
-116.89%
TTM Avg
-117.72%
3Y Avg
-83.78%
5Y Avg
-61.46%
Market Cap
$4.53M
Return on Invested Capital (ROIC)
-19.51%
TTM Avg
-11.65%
3Y Avg
-12.10%
5Y Avg
-17.92%
Market Cap
$4.55M
Return on Invested Capital (ROIC)
-246.61%
TTM Avg
-463.24%
3Y Avg
-303.42%
5Y Avg
-359.05%
Market Cap
$4.21M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-480.55%
3Y Avg
-363.38%
5Y Avg
-260.65%
Market Cap
$4.15M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-199.78%
3Y Avg
-1598.70%
5Y Avg
-1598.70%
Market Cap
$4.69M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-179.66%
3Y Avg
-275.36%
5Y Avg
-182.57%
Market Cap
$4.71M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
Market Cap
$4.72M
Return on Invested Capital (ROIC)
-38.23%
TTM Avg
-122.97%
3Y Avg
-1403.32%
5Y Avg
-860.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CollPlant Biotechnologies Ltd. (CLGN) | $4.40M | -221.32% | -148.05% | -93.66% | -59.62% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -116.89% | -117.72% | -83.78% | -61.46% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | -19.51% | -11.65% | -12.10% | -17.92% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | -246.61% | -463.24% | -303.42% | -359.05% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | N/A | -480.55% | -363.38% | -260.65% |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | -199.78% | -1598.70% | -1598.70% |
| CalciMedica, Inc. (CALC)vs › | $4.69M | -122.56% | -179.66% | -275.36% | -182.57% |
| Imunon, Inc. (IMNN)vs › | $4.71M | -126.69% | -289.57% | -198.60% | -147.26% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | -38.23% | -122.97% | -1403.32% | -860.06% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | -43.50% | -54.16% | -50.91% | -58.12% |
ROIC
-221.3%
ROE
-424.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -221.32% |
| 2026-03-31 | -192.11% |
| 2025-12-31 | -128.63% |
| 2025-09-30 | -107.42% |
| 2025-06-30 | -90.79% |
| 2025-03-31 | -100.43% |
| 2024-12-31 | -109.60% |
| 2024-09-30 | -94.69% |
| 2024-06-30 | -78.91% |
| 2024-03-31 | -30.97% |
| 2023-12-31 | -24.33% |
| 2023-09-30 | -20.39% |
| 2023-06-30 | -18.01% |
| 2023-03-31 | -51.31% |
| 2022-12-31 | -49.32% |
| 2022-09-30 | -42.45% |
| 2022-06-30 | -35.32% |
| 2022-03-31 | -29.77% |
| 2021-12-31 | 0.13% |
| 2021-09-30 | 2.26% |
| 2021-06-30 | 9.57% |
| 2021-03-31 | 11.52% |
| 2020-12-31 | -75.12% |
| 2020-09-30 | -58.30% |
| 2020-06-30 | -93.36% |
| 2020-03-31 | -78.26% |
| 2019-12-31 | -107.91% |
| 2019-09-30 | -56.61% |
| 2019-06-30 | -66.97% |
| 2019-03-31 | -46.71% |
| 2018-12-31 | -63.00% |
| 2018-09-30 | -130.93% |
| 2018-06-30 | -121.03% |
| 2018-03-31 | -121.23% |
| 2017-12-31 | -88.50% |
| 2017-09-30 | -451.12% |
| 2017-06-30 | -287.16% |
| 2017-03-31 | -244.94% |
| 2016-12-31 | -358.19% |
| 2016-09-30 | -193.42% |
| 2016-06-30 | -149.90% |
| 2016-03-31 | -204.67% |
| 2015-12-31 | -193.61% |
| 2015-09-30 | -105.99% |
| 2015-06-30 | -170.15% |
| 2015-03-31 | -598.05% |
| 2014-12-31 | -102.35% |
| 2014-09-30 | -85.05% |
| 2014-06-30 | -20.70% |
| 2014-03-31 | -64.30% |
| 2013-12-31 | -58.08% |
| 2013-09-30 | -366.34% |
| 2013-06-30 | -227.24% |
